Latest AI Stock Forecasts - All Predictions

Signal date 2026-10-16 Cut-offs from the 2026-10-16 run

Companies scored 2758 IC ≥ 0 · market cap ≥ $100M

Median forecast +0.74% Total · 30D

Long–short spread +2.79% Strong Buy minus Strong Sell, mean

Median IC 0.17 Spearman · 30D

Rating changes ▲ 239 ▼ 399 vs the previous run

Cross-section

Distribution of the day's forecasts

30D Total forecasts of every company scored, cut into five relative ratings at the 15th, 35th, 65th and 85th percentiles (dashed lines).

-1.3% 0 +3.6%

Signals · All

296 companies

Sorted by market cap ↓ · forecast rankings are part of the paid plans

#	Ticker	Sector	IC	Mkt cap	Rating	30D	90D	Δ
151	REPLReplimune Group, Inc.	Life Sciences	0.27	$1.0B	Unlock rating and forecasts
152	MNKDMANNKIND CORP	Life Sciences	0.30	$977M	Unlock rating and forecasts
153	IMTXImmatics N.V.	Life Sciences	0.30	$902M	Unlock rating and forecasts
154	MGTXMeiraGTx Holdings plc	Life Sciences	0.19	$891M	Neutral	+0.87%	+2.95%	·
155	QDELQuidelOrtho Corp	Life Sciences	0.09	$885M	Neutral	+1.06%	+3.59%	·
156	ANROAlto Neuroscience, Inc.	Life Sciences	0.24	$861M	Unlock rating and forecasts
157	RIGLRIGEL PHARMACEUTICALS INC	Life Sciences	0.13	$859M	Neutral	+0.82%	+2.58%	·
158	CYRXCryoport, Inc.	Life Sciences	0.31	$853M	Neutral	+1.04%	+3.28%	·
159	ABUSArbutus Biopharma Corp	Life Sciences	0.13	$835M	Unlock rating and forecasts
160	CGEMCullinan Therapeutics, Inc.	Life Sciences	0.32	$832M	Unlock rating and forecasts
161	GLUEMonte Rosa Therapeutics, Inc.	Life Sciences	0.00	$831M	Unlock rating and forecasts
162	AVBPArriVent BioPharma, Inc.	Life Sciences	0.00	$821M	Unlock rating and forecasts
163	ALMSALUMIS INC.	Life Sciences	-0.01	$792M	Unlock rating and forecasts
164	VSTMVerastem, Inc.	Life Sciences	0.23	$783M	Unlock rating and forecasts
165	HELPHelus Pharma Inc.	Life Sciences	0.05	$771M	Unlock rating and forecasts
166	ARDXARDELYX, INC.	Life Sciences	0.27	$770M	Neutral	+0.68%	+2.30%	·
167	COLLCOLLEGIUM PHARMACEUTICAL, INC	Life Sciences	0.15	$755M	Unlock rating and forecasts
168	GERNGERON CORP	Life Sciences	-0.10	$752M	Unlock rating and forecasts
169	IVAInventiva S.A.	Life Sciences	0.21	$709M	Unlock rating and forecasts
170	DNAGinkgo Bioworks Holdings, Inc.	Life Sciences	0.17	$692M	Unlock rating and forecasts
171	SANASana Biotechnology, Inc.	Life Sciences	0.33	$680M	Unlock rating and forecasts
172	LXRXLEXICON PHARMACEUTICALS, INC.	Life Sciences	0.36	$676M	Unlock rating and forecasts
173	FDMT4D Molecular Therapeutics, Inc.	Life Sciences	0.32	$670M	Unlock rating and forecasts
174	IMMXImmix Biopharma, Inc.	Life Sciences	0.34	$662M	Unlock rating and forecasts
175	ACHVACHIEVE LIFE SCIENCES, INC.	Life Sciences	0.29	$657M	Unlock rating and forecasts
176	ANNXAnnexon, Inc.	Life Sciences	0.19	$646M	Unlock rating and forecasts
177	DSGNDesign Therapeutics, Inc.	Life Sciences	0.23	$645M	Unlock rating and forecasts
178	GYREGYRE THERAPEUTICS, INC.	Life Sciences	0.16	$645M	Unlock rating and forecasts
179	AURAAura Biosciences, Inc.	Life Sciences	0.31	$633M	Unlock rating and forecasts
180	PRMEPrime Medicine, Inc.	Life Sciences	0.20	$629M	Unlock rating and forecasts
181	CADLCandel Therapeutics, Inc.	Life Sciences	0.18	$627M	Unlock rating and forecasts
182	WVEWave Life Sciences, Inc.	Life Sciences	0.24	$617M	Neutral	+1.13%	+3.32%	·
183	AVTXAvalo Therapeutics, Inc.	Life Sciences	0.20	$604M	Unlock rating and forecasts
184	SLDBSolid Biosciences Inc.	Life Sciences	0.21	$593M	Unlock rating and forecasts
185	IRWDIRONWOOD PHARMACEUTICALS INC	Life Sciences	0.21	$578M	Neutral	+1.12%	+3.56%	·
186	OLMAOlema Pharmaceuticals, Inc.	Life Sciences	0.37	$576M	Unlock rating and forecasts
187	SGMTSagimet Biosciences Inc.	Life Sciences	0.02	$569M	Unlock rating and forecasts
188	CRMDCorMedix Inc.	Life Sciences	0.06	$566M	Neutral	+0.61%	+2.18%	·
189	CLYMClimb Bio, Inc.	Life Sciences	0.30	$564M	Unlock rating and forecasts
190	PHATPhathom Pharmaceuticals, Inc.	Life Sciences	-0.02	$560M	Unlock rating and forecasts
191	STTKShattuck Labs, Inc.	Life Sciences	0.20	$544M	Unlock rating and forecasts
192	DBVTDBV Technologies S.A.	Life Sciences	0.38	$536M	Neutral	+0.52%	+1.92%	▲ 1
193	SLNSilence Therapeutics plc	Life Sciences	-0.10	$522M	Unlock rating and forecasts
194	DRUGBRIGHT MINDS BIOSCIENCES INC.	Life Sciences	0.28	$512M	Unlock rating and forecasts
195	PBYIPUMA BIOTECHNOLOGY, INC.	Life Sciences	0.15	$507M	Unlock rating and forecasts
196	CBIOGYRE THERAPEUTICS, INC.	Life Sciences	0.07	$507M	Unlock rating and forecasts
197	CTMXCytomX Therapeutics, Inc.	Life Sciences	-0.02	$497M	Unlock rating and forecasts
198	FTHFaeth Therapeutics, Inc.	Life Sciences	0.07	$486M	Unlock rating and forecasts
199	ACRSAclaris Therapeutics, Inc.	Life Sciences	0.19	$483M	Unlock rating and forecasts
200	EOLSEvolus, Inc.	Life Sciences	0.22	$469M	Unlock rating and forecasts

Breadth

By sector

Median 30D forecast per sector. Click to filter.

Life Sciences296 +1.6% Finance or Crypto Assets48 +1.6% Technology381 +1.0% Manufacturing434 +0.7% Trade & Services356 +0.6% Energy & Transportation313 +0.6% Industrial Applications and Services290 +0.6% Finance395 +0.6% Real Estate & Construction233 +0.5% Crypto Assets12 -0.2%

Since the previous run

Rating changes

▲ 239▼ 399

Which companies were upgraded or downgraded is part of the paid plans.

Next step

Unlock the full ranking

Every company's rating, its 30- and 90-day forecasts, the forecast and IC-weighted rankings, the daily rating changes and CSV export.

See plans Create a free account

Methodology

Ratings are relative: the forecasts of the latest complete daily run (2026-10-16) are ranked and cut at the 15th, 35th, 65th and 85th percentiles, so Strong Sell is the bottom 15%, Sell the next 20%, Neutral the middle 30%, Buy the next 20% and Strong Buy the top 15%. Expected absolute price move over the horizon, market included. This is the number a price target is built from. IC is the company's Spearman information coefficient between its past forecasts and the realised returns at the selected horizon; IC-weighted ranking multiplies each forecast by its IC (negative IC counts as zero). Δ is the rating move since the company's previous signal, in rating steps. Each company shows its latest signal, including one from a run still in progress; every signal is rated against the cut-offs above. Quantitative research output, not investment advice.

Daily Signals

Distribution of the day's forecasts

296 companies

By sector

Rating changes

Unlock the full ranking

Intratio Assistant

Cookie Settings

Essential Cookies

Analytics Cookies

Daily Signals

Distribution of the day's forecasts

296 companies

By sector

Rating changes

Unlock the full ranking